Review article · 2020 · Open access
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019
Journal of Natural Products, 83(3), 770–803 · Published 12 March 2020 · DOI 10.1021/acs.jnatprod.9b01285
In brief
“Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019” is a 2020 review article by David J. Newman and Gordon M. L. Cragg, published in Journal of Natural Products. OpenAlex counts 7,777 citations as of 15 November 2026. It is open access: the full text is free to read at Journal of Natural Products.
- Citations
- 7,777
- Most cited in
- 2026 (1,792)
- Field-weighted impact
- 62.23
- References
- 134
- Authors
- 2
Abstract
This review is an updated and expanded version of the five prior reviews that were published in this journal in 1997, 2003, 2007, 2012, and 2016. For all approved therapeutic agents, the time frame has been extended to cover the almost 39 years from the first of January 1981 to the 30th of September 2019 for all diseases worldwide and from ∼1946 (earliest so far identified) to the 30th of September 2019 for all approved antitumor drugs worldwide. As in earlier reviews, only the first approval of any drug is counted, irrespective of how many "biosimilars" or added approvals were subsequently identified. As in the 2012 and 2016 reviews, we have continued to utilize our secondary subdivision of a "natural product mimic", or "NM", to join the original primary divisions, and the designation "natural product botanical", or "NB", to cover those botanical "defined mixtures" now recognized as drug entities by the FDA (and similar organizations). From the data presented in this review, the utilization of natural products and/or synthetic variations using their novel structures, in order to discover and develop the final drug entity, is still alive and well. For example, in the area of cancer, over the time frame from 1946 to 1980, of the 75 small molecules, 40, or 53.3%, are N or ND. In the 1981 to date time frame the equivalent figures for the N* compounds of the 185 small molecules are 62, or 33.5%, though to these can be added the 58 S* and S*/NMs, bringing the figure to 64.9%. In other areas, the influence of natural product structures is quite marked with, as expected from prior information, the anti-infective area being dependent on natural products and their structures, though as can be seen in the review there are still disease areas (shown in Table 2) for which there are no drugs derived from natural products. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are still able to identify only two de novo combinatorial compounds (one of which is a little speculative) approved as drugs in this 39-year time frame, though there is also one drug that was developed using the "fragment-binding methodology" and approved in 2012. We have also added a discussion of candidate drug entities currently in clinical trials as "warheads" and some very interesting preliminary reports on sources of novel antibiotics from Nature due to the absolute requirement for new agents to combat plasmid-borne…
Cite this paper
Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.
APA 7
Newman, D. J., & Cragg, G. M. L. (2020). Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
MLA 9
Newman, David J., and Gordon M. L. Cragg. “Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.” Journal of Natural Products, vol. 83, no. 3, 2020, pp. 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285.
Chicago
Newman, David J. and Gordon M. L. Cragg. 2020. “Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.” Journal of Natural Products 83 (3): 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285.
Harvard
Newman, D. J. and Cragg, G. M. L. (2020) ‘Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019’, Journal of Natural Products, 83(3), pp. 770–803. doi:10.1021/acs.jnatprod.9b01285.
IEEE
D. J. Newman and G. M. L. Cragg, “Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019,” Journal of Natural Products, vol. 83, no. 3, pp. 770–803, 2020, doi: 10.1021/acs.jnatprod.9b01285.
BibTeX
@article{newman2020natural,
title = {{Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019}},
author = {Newman, David J. and Cragg, Gordon M. L.},
journal = {Journal of Natural Products},
year = {2020},
volume = {83},
number = {3},
pages = {770--803},
doi = {10.1021/acs.jnatprod.9b01285},
url = {https://doi.org/10.1021/acs.jnatprod.9b01285}
}
Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)
Citations by year
| Year | Citations | Share of the best year |
|---|---|---|
| 2015 | 1 | |
| 2020 | 245 | |
| 2021 | 784 | |
| 2022 | 1,108 | |
| 2023 | 1,088 | |
| 2024 | 1,313 | |
| 2025 | 1,442 | |
| 2026 | 1,792 |
Its field-weighted citation impact is 62.23: it has been cited 62.23 times as often as the average work of the same field, type and year (1.00 is the world average).
Topic and keywords
Life Sciences › Immunology and Microbiology › Applied Microbiology and Biotechnology › Microbial Natural Products and Biosynthesis
- natural products
- drug discovery
- drug approval
- anticancer agents
- anti-infective agents
- combinatorial chemistry
- structure-activity relationship
- synthetic analogues
Work with this paper
Most-cited papers in Immunology and Microbiology
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Ulrich K. Laemmli · Nature · 1970 · 249,784 citations
- Atherosclerosis — An Inflammatory DiseaseRussell Ross · New England Journal of Medicine · 1999 · 21,957 citations
- Continuous cultures of fused cells secreting antibody of predefined specificityGeorges Köhler, César Milstein · Nature · 1975 · 17,450 citations
- Inflammation and cancerLisa M. Coussens, Zena Werb · Nature · 2002 · 15,462 citations
- Dendritic cells and the control of immunityJacques Banchereau, Ralph M. Steinman · Nature · 1998 · 14,526 citations
Questions about this paper
How do I cite this paper in APA style?
Newman, D. J., & Cragg, G. M. L. (2020). Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019. Journal of Natural Products, 83(3), 770–803. https://doi.org/10.1021/acs.jnatprod.9b01285
How many times has this paper been cited?
7,777 times, according to OpenAlex on 15 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.
Is this paper free to read?
Yes. It is open access: read the free full text at Journal of Natural Products.
Who wrote this paper?
David J. Newman, Gordon M. L. Cragg.
What is the DOI of this paper?
10.1021/acs.jnatprod.9b01285. The permanent link is https://doi.org/10.1021/acs.jnatprod.9b01285.
Bibliographic data from OpenAlex (CC0), last checked 15 November 2026. ResearchGuru does not host this paper; the links go to the publisher or the repository that does.